More News! 24 Aug 2018
Shire gets US market approval for rare inflammatory disease drug
The UK-US biotech giant’s drug Takhzyro has been approved by the FDA to prevent attacks of hereditary angioedema, a rare…
Shire
- Latest Posts
News and Trends 28 Feb 2018
Like Finding a Needle in a Haystack: How Are Biotechs Fighting Rare Diseases?
Rare diseases affect fewer than 1 in 2,000 people in Europe and less than 200,000 Americans at any given time.…
News and Trends 20 Feb 2018
Microsoft Joins Shire to Diagnose Rare Diseases Much Faster
Microsoft has partnered with Shire and EURORDIS to accelerate the diagnosis of rare disease, a process that often takes years…
In Depth 13 Feb 2018
How is Biotech Innovating to Treat Hemophilia? Let’s Review
Experts say hemophilia treatment is at a 'precipice of a therapeutic revolution.' From antibodies to gene therapy, here are some…
ADVERTISEMENT
More News! 12 Sep 2017
Shire’s Treatment for Chronic Lung Disease in Premature Infants Fast Tracked by FDA
The FDA has fast tracked Shire's candidate for chronic lung disease in extremely premature infants from Phase 2 of clinical…
News and Trends 18 Jul 2017
Shire In-Licenses Swiss Antibody for Hemophilia A to Compete with Roche
Shire has bought exclusive worldwide rights to develop and commercialize a bispecific antibody from Novimmune that could improve the treatment…
News and Trends 13 Jun 2017
German Biotech Raises €25M to Fuel Diagnostics of Rare Diseases
Centogene has raised €25M in a Series A round to support the global expansion of its genome analysis platform, which is…
News and Trends 5 Jan 2017
Shire sells its RNA platform to a US-based Biotech
Shire has sold its RNA therapy program to a smaller biotech that wants to accelerate the development of products from…
News and Trends 7 Nov 2016
Results from 45% of Clinical Trials are kept Secret
A new transparency study has identified Sanofi, Novartis and GSK as the companies that keep the most clinical trial results unreported.…
News and Trends 18 Oct 2016
Shire’s leading Pancreatic Cancer drug is Back with a Bang
Pancreatic cancer is one of the nastiest kinds and most difficult to treat; the EMA has granted marketing authorization to…
ADVERTISEMENT
News and Trends 14 Jan 2016
The Biotech World is Buzzing: J.P. Morgan’s 2016 Phenomenon Kicks off this Week!
Imagine a conference where all the Biotech CEOs and investors of the World come together...all the major players in this…
News and Trends 7 Jan 2016
Collaboration is Key to Microbiomics: New Deal with The Janssen Human Microbiome Institute
The Janssen Human Microbiome Institute, the French National Institute for Agricultural Research (INRA) and Johnson & Johnson Innovation AND Takeda…
News and Trends 4 Nov 2015
Transformational deals that shaped the Biotech industry in 2015 #BIO-Europe 2015
The Biotech industry relies a lot on partnering and deals. And 2015 has already been an active year. This was…
News and Trends 21 Sep 2015
Shire’s Adderall alternative granted EMA approval for EU
Intuniv, Shire's new anti-stimulatory product for children with attention-deficit hyperactivity disorder (ADHD) between 6-17 years old, is set to hit shelves…
News and Trends 10 Mar 2015
Live from Bio-Europe 2015: The product development challenges in the gene therapy field
Gene Therapy is really the hot topic right now in the field of Biotech especially with technologies such as CRISPR and…